Loading…
CIK 0001056807 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("bvf-inc-il","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS IN | COM | $40.2M | 1.6%Prev: 1.0% | 4,629,289 SH | Increased+1,750,000 SH |
| ABIVAX SA | SPONSORED ADS | $47.4M | 1.9% | 558,031 SH | New |
| AC IMMUNE SA | SHS | $57.3M | 2.3%Prev: 1.2% | 19,822,436 SH | Increased |
| ANNEXON INC | COM | $21.4M | 0.9%Prev: 1.3% | 7,000,000 SH | Decreased-1,698,173 SH |
| AVALO THERAPEUTICS INC | COM NEW | $17.2M | 0.7%Prev: 1.0% | 1,355,256 SH | Decreased-720,289 SH |
| AXSOME THERAPEUTICS INC | COM | $59.1M | 2.4% | 486,757 SH | New |
| CELCUITY INC | COM | $32.5M | 1.3% | 658,421 SH | New |
| CIDARA THERAPEUTICS INC | COM NEW | $135.4M | 5.5% | 1,414,165 SH | New |
| COMPASS THERAPEUTICS INC | COM | $16.6M | 0.7% | 4,750,000 SH | New |
| CRESCENT BIOPHARMA INC. | COM | $16.5M | 0.7%Prev: 1.3% | 1,387,863 SH | Decreased-1,360,900 SH |
| CULLINAN THERAPEUTICS INC | COM | $34.1M | 1.4%Prev: 2.7% | 5,750,683 SH | Decreased |
| ELEDON PHARMACEUTICALS INC | COM | $16.3M | 0.7%Prev: 0.6% | 6,293,282 SH | Decreased |
| ENGENE HOLDINGS INC | *W EXP 10/31/202 | $681K | 0.0% | 945,402 SH | New |
| ESSA PHARMA INC | COM NEW | $2.2M | 0.1% | 11,668,473 SH | New |
| FOGHORN THERAPEUTICS INC | COM | $25.9M | 1.1%Prev: 0.7% | 5,302,000 SH | Decreased-540,000 SH |
| FORTE BIOSCIENCES INC | COM NEW | $980K | 0.0% | 65,350 SH | New |
| GH RESEARCH PLC | ORDINARY SHARES | $126.2M | 5.1%Prev: 5.9% | 8,827,712 SH | Decreased+177,554 SH |
| IMAGENEBIO INC | COM | $6.5M | 0.3%Prev: 0.2% | 802,102 SH | Decreased-307,900 SH |
| IMMUNIC INC | COM | $6.7M | 0.3% | 7,652,972 SH | New |
| IMMUNOCORE HLDGS PLC | ADS | $57.2M | 2.3%Prev: 1.1% | 1,574,288 SH | Increased+279,825 SH |
| INVENTIVA SA | ADS | $4.0M | 0.2%Prev: 0.1% | 686,040 SH | Increased |
| KURA ONCOLOGY INC | COM | $76.3M | 3.1%Prev: 2.4% | 8,617,162 SH | Decreased+171,393 SH |
| KYMERA THERAPEUTICS INC | COM | $311.5M | 12.6%Prev: 11.4% | 5,502,710 SH | Decreased+1,630,658 SH |
| MIRUM PHARMACEUTICALS INC | COM | $109.6M | 4.4%Prev: 3.2% | 1,495,290 SH | Decreased+439,263 SH |
| MOLECULAR PARTNERS AG | ADS | $5.0M | 0.2%Prev: 0.1% | 1,353,968 SH | Decreased |
| MONTE ROSA THERAPEUTICS INC | COM | $41.9M | 1.7%Prev: 2.8% | 5,660,132 SH | Decreased+1,199,246 SH |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $141.6M | 5.7%Prev: 8.0% | 19,751,284 SH | Decreased+3,750,000 SH |
| NEKTAR THERAPEUTICS | COM NEW | $72.6M | 2.9%Prev: 4.3% | 1,276,595 SH | Decreased-1,114,480 SH |
| NLS PHARMACEUTICS LTD | COM NEW | $263K | 0.0% | 143,676 SH | New |
| OLEMA PHARMACEUTICALS INC | COM | $51.8M | 2.1%Prev: 1.7% | 5,295,893 SH | Decreased |
| PALVELLA THERAPEUTICS INC NE | COM | $72.8M | 3.0%Prev: 2.6% | 1,161,249 SH | Decreased+488,460 SH |
| PEPGEN INC | COM | $8.8M | 0.4% | 1,915,000 SH | New |
| PROTAGONIST THERAPEUTICS INC | COM | $170.1M | 6.9% | 2,560,916 SH | New |
| REPARE THERAPEUTICS INC | COM | $18.2M | 0.7% | 10,333,600 SH | New |
| REVOLUTION MEDICINES INC | COM | $185.6M | 7.5%Prev: 14.2% | 3,974,913 SH | Decreased+1,009,753 SH |
| SAB BIOTHERAPEUTICS INC | COM NEW | $1.9M | 0.1% | 932,697 SH | New |
| SEPTERNA INC | COM | $75.5M | 3.1% | 4,015,790 SH | New |
| STOKE THERAPEUTICS INC | COM | $38.9M | 1.6%Prev: 2.1% | 1,657,096 SH | Decreased-890,461 SH |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $89.7M | 3.6%Prev: 4.6% | 3,203,917 SH | Decreased-162,906 SH |
| TENAX THERAPEUTICS INC | COM NEW | $2.6M | 0.1%Prev: 0.1% | 339,549 SH | Decreased |
| TSCAN THERAPEUTICS INC | COM | $9.5M | 0.4%Prev: 0.1% | 5,226,074 SH | Increased-338,216 SH |
| TYRA BIOSCIENCES INC | COM | $51.1M | 2.1%Prev: 1.2% | 3,649,794 SH | Increased+2,173,598 SH |
| X4 PHARMACEUTICALS INC | COM NEW | $7.6M | 0.3%Prev: 0.3% | 2,233,742 SH | Decreased |
| XENCOR INC | COM | $32.1M | 1.3%Prev: 2.9% | 2,740,141 SH | Decreased-4,393,579 SH |
| XOMA ROYALTY CORPORATION | COM NEW | $99.8M | 4.0%Prev: 8.3% | 2,590,303 SH | Decreased-5,003,000 SH |
| ZYMEWORKS INC | COM | $67.3M | 2.7%Prev: 2.4% | 3,938,641 SH | Decreased+289,499 SH |
| 13F-HR |
| 0000921895-26-002163 |
| $3.91B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000921895-25-002281 | $2.80B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000921895-26-001382 | $3.14B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000921895-25-001528 | $2.45B | View |